Covid-19 Vaccine Janssen - Important Safety Information from Janssen Sciences Ireland UC as approved by the HPRA (19 July 2021)

Notice type: 3rd Party Publications

Date: 19/07/2021

 

Problem Or Issue:
Important Safety Information from Janssen Sciences Ireland UC regarding Covid-19 Vaccine Janssen: Contraindication in individuals with previous capillary leak syndrome and update on thrombosis with thrombocytopenia syndrome

Important Safety Information - Covid-19 Vaccine Janssen


« Back